Private Label Kojic Acid Tranexamic Acid Body Serum Low MOQ

The minimum order quantity for a private label kojic acid and tranexamic acid body serum depends almost entirely on whether you choose a stock (white-label) formula or pursue custom development. For stock formulas — where a manufacturer already has a finished, stability-tested brightening serum they apply your label to — MOQs typically start at 100 to 300 units per SKU. These are the lowest entry points in the market and are ideal for founders testing a concept, validating a niche, or launching a limited run on a platform like Shopify or Amazon. Semi-custom programs, where you can adjust the concentration of kojic acid, tranexamic acid, or add supporting ingredients like niacinamide or alpha arbutin, generally require 300 to 1,000 units. These programs cost more per unit than pure white-label because the manufacturer has to run a separate batch and potentially conduct additional compatibility testing. Full custom formulation — where a cosmetic chemist develops a formula from scratch to your specification — almost always requires a minimum of 1,000 units, and many established US and European labs set the floor at 2,000 to 5,000 units. This is because the development cost (lab hours, stability testing, micro testing, regulatory documentation) must be amortized across enough units to make the project financially viable for the manufacturer. Overseas manufacturers in China, South Korea, and parts of Latin America often quote lower per-unit costs but typically require 500 to 2,000 units and have lead times that include ocean freight, which adds 4 to 8 weeks to your timeline. You also take on more quality oversight responsibility when manufacturing internationally. One factor that moves MOQs downward: if you're willing to use stock packaging (the manufacturer's existing bottle or tube shape) rather than custom-molded components, most suppliers will reduce their MOQ by 20–40%. Combining a stock formula with stock packaging is the fastest, cheapest, lowest-MOQ route to market. A common mistake first-time founders make is negotiating MOQ without confirming what's included. Some manufacturers quote MOQ for the filling step only — labeling, capping, shrink banding, and batch documentation are billed separately. Always ask for a landed cost per unit that includes all finishing steps. Platforms like AJ Cosmo Labs let you post your MOQ requirement as a filter in your product brief so that only manufacturers who can genuinely meet your volume respond — saving you from hours of back-and-forth with suppliers whose minimums don't match your budget.

The total cost to private label a kojic acid and tranexamic acid body serum has several components: formulation or licensing fees, raw material costs, filling and manufacturing fees, packaging, labeling, testing, and regulatory compliance documentation. Understanding each layer helps you build a realistic P&L before you commit to a supplier. For a stock white-label serum, the cost per finished unit typically ranges from $4 to $9, depending on fill volume (most body serums are 150–250 ml), the concentration of actives, and the packaging tier. At 300 units, expect to be at the higher end of that range. At 1,000+ units the same formula often drops to $5–$6.50 per unit. Semi-custom development adds a formulation adjustment fee, usually $500 to $2,500 as a one-time R&D charge, plus the finished unit cost of $7 to $15 depending on ingredient complexity. If you're adding premium supporting actives like azelaic acid, glutathione, or licorice root extract alongside the kojic acid and tranexamic acid, raw material costs increase accordingly. Full custom formulation carries a development fee ranging from $1,500 to $8,000+ depending on the lab's seniority, number of formula iterations, and the scope of stability and micro testing included. Stability testing alone (accelerated 3-month real-time protocol) typically costs $800 to $2,500 at a third-party testing house. Challenge testing (USP 51) adds another $400 to $1,000. Packaging is often the largest variable. A stock PET or glass pump bottle with a silkscreen label might cost $0.60 to $1.50 per unit at low MOQ. A custom-molded bottle with hot stamping, frosted finish, and a secondary carton can push packaging costs to $3 to $6 per unit — sometimes more than the formula itself at small volumes. Labeling and regulatory compliance documents — including INCI labeling review, safety data sheets, and (if targeting the EU) a Cosmetic Product Safety Report — typically add $500 to $3,000 depending on the markets you're entering. As a rough all-in benchmark: a 200-unit white-label launch of a 150ml brightening body serum typically costs $3,000 to $6,000 total. A 1,000-unit semi-custom launch with proprietary packaging often runs $12,000 to $25,000. These are real ranges based on typical supplier pricing — not guarantees, and quotes vary significantly by geography and manufacturer tier. AJ Cosmo Labs lets you post your budget range alongside your product brief so you receive manufacturer responses that are already financially aligned with your project, rather than discovering mismatches three calls in.

The manufacturing timeline for a private label kojic acid and tranexamic acid body serum breaks down into distinct stages, each with its own minimum clock time. Understanding the full sequence helps you plan launch dates, investor pitches, and influencer seeding campaigns without getting burned by avoidable delays. Stage 1 — Supplier selection and NDA/agreement signing: 1 to 3 weeks. This is often underestimated. Reviewing quotes, negotiating terms, signing NDAs, and executing a manufacturing or supply agreement realistically takes 1 to 3 weeks even when both parties are motivated. Stage 2 — Formula development or stock formula confirmation: 1 to 8 weeks. For a stock white-label product, this stage can be as short as 1 week — you review the formula card, confirm concentrations, and approve. For semi-custom (adjusting kojic acid from 1% to 1.5%, for example), expect 2 to 4 weeks for lab adjustments. Full custom development typically takes 4 to 8 weeks before a first prototype is ready. Stage 3 — Sample review and revision: 2 to 6 weeks. You receive 1 to 3 prototypes, evaluate texture, scent, pH, packaging fit, and skin feel on test subjects. Each revision cycle adds 1 to 2 weeks. Budget for at least two rounds. Stage 4 — Stability and micro testing: 4 to 12 weeks if done properly. Accelerated stability (stored at 40°C/75% RH for 3 months) takes a minimum of 12 weeks in real time. Some brands launch on in-process data at the 4-week checkpoint and accept the risk; this is not best practice but is common in the indie brand space for stock formulas that already carry existing stability data from the manufacturer. Stage 5 — Packaging production and procurement: 4 to 10 weeks. Custom-molded components have the longest lead times. Stock packaging can be sourced in 2 to 4 weeks domestically, or 6 to 10 weeks from overseas suppliers. Stage 6 — Production fill and finishing: 2 to 4 weeks once all components are in-house at the manufacturer. Total realistic timeline for a white-label launch with stock packaging: 6 to 10 weeks. Total for a semi-custom launch with proprietary packaging: 14 to 20 weeks. Total for a full custom launch: 20 to 30 weeks. The biggest timeline killers are packaging delays, too many sample revision rounds, and brands that don't have their label artwork finalized before production begins. Have your label files print-ready before you sign the manufacturing agreement. Using AJ Cosmo Labs to post your brief and filter by manufacturers with existing brightening serum formulas dramatically compresses Stage 2 and Stage 3, which is where most indie founders lose 4 to 8 weeks.

Kojic acid is a well-established cosmetic ingredient derived from fungal fermentation (commonly Aspergillus oryzae) and is used extensively in brightening and anti-hyperpigmentation products. When used at appropriate concentrations in a well-formulated base, it has a strong safety profile for topical application, with decades of use in Japanese skincare and significant peer-reviewed literature supporting its efficacy. For body serums, the typically effective and cosmetically accepted concentration range for kojic acid is 0.5% to 2%. The 1% to 1.5% range is most common in commercially produced private label products because it balances efficacy with formulation stability. Concentrations above 2% increase the risk of irritation, particularly on sensitive or compromised skin, and can accelerate formula discoloration — the most persistent formulation challenge with this ingredient. Kojic acid is notoriously prone to oxidation, which causes the formula to turn yellow or brown. Experienced cosmetic chemists mitigate this with chelating agents (like EDTA), antioxidants (like ferulic acid or vitamin E), careful pH management (typically kept between 3.5 and 5.5), and appropriate packaging (airless pumps or opaque UV-protective bottles). When evaluating a manufacturer's stock formula, ask specifically what stability controls they use for kojic acid color stability — it's a litmus test for their formulation expertise. For tranexamic acid, the effective topical range is 2% to 5%. At 2–3%, tranexamic acid has demonstrated measurable reduction in melasma and PIH (post-inflammatory hyperpigmentation) in clinical studies, particularly with consistent daily use over 8 to 12 weeks. The two actives complement each other mechanistically: kojic acid acts primarily on tyrosinase, while tranexamic acid interrupts UV-induced plasminogen activator pathways that stimulate melanocyte activity. Safety considerations to address in your product: both ingredients can cause irritation in individuals with compromised skin barriers. Kojic acid specifically is a known sensitizer at high concentrations and long-term use. It is on California's Prop 65 list, which requires a warning on products sold in California unless the brand can establish that exposure is below the safe harbor level. A regulatory consultant can help you determine whether your formula's concentration and intended use pattern triggers the warning requirement. Kojic acid is restricted in the EU — currently to a maximum of 1% in face products — and the status for body products is actively under review by the Scientific Committee on Consumer Safety (SCCS). Brands targeting EU markets should verify the current Annex restriction before manufacturing. Transexamic acid has no significant restrictions in the US, EU, or Canada at cosmetic use levels and is considered a well-tolerated, low-irritation brightening active — one reason formulators favor it over more sensitizing agents like hydroquinone. AJ Cosmo Labs connects you with cosmetic chemists and manufacturers who can advise on the exact concentration, pH, and preservation system appropriate for your target demographic and geography.

Finding a reputable private label manufacturer for a kojic acid and tranexamic acid body serum requires more diligence than a quick Google search, because not every contract manufacturer that claims brightening expertise has actually formulated with these specific actives at scale. The vetting process has several distinct steps. Step 1: Define your requirements before outreach. Know your target MOQ, fill volume, active concentrations, target markets (which determines regulatory standards), packaging format (pump, tube, dropper), and budget range. Manufacturers qualify and prioritize projects faster when you arrive with specifics. Step 2: Establish baseline GMP credentials. For US-distributed products, verify that the manufacturer is FDA-registered as a cosmetic facility (required since the MoCRA update took effect in 2023 for most domestic manufacturers). Ask whether they follow ISO 22716 (Good Manufacturing Practices for Cosmetics) and request their most recent third-party GMP audit report. Overseas manufacturers should carry equivalent GMP certification — KGMP (Korean GMP) or CGMP — if they're supplying compliant international brands. Step 3: Request existing formula data. Ask specifically for a formula card or technical data sheet for a brightening body serum they currently manufacture. A legitimate manufacturer with relevant experience will have stability data, a full INCI list, pH specification, and micro testing results already on file. If they can't provide this for any existing brightening formula, they're either new to the category or disorganized — neither is a good sign for a stability-sensitive product like a kojic acid serum. Step 4: Evaluate communication quality. How quickly do they respond? Do they ask clarifying questions about your formula goals, or do they immediately push you toward their cheapest stock SKU? A manufacturer who engages seriously with your brief — asking about target skin tone, regional distribution, SPF compatibility, pH preference — is demonstrating category knowledge. Step 5: Request references or case studies. Ask for examples of brightening product brands they've manufactured for. You may not get names due to NDAs, but a manufacturer with real experience can describe the project type, fill volume, and challenge they solved without revealing confidential client information. Step 6: Pilot with a sample order before committing to production. Any reputable manufacturer will send paid samples. Evaluate texture, color stability (test at room temperature and in a warm environment for 4 weeks), packaging fit, and on-skin performance before signing a production PO. Common red flags: manufacturers who can't produce a CoA for their actives, who resist GMP documentation requests, who quote you without asking about your target market, or who have no references or verifiable brand clients. AJ Cosmo Labs streamlines this entire process. The iOS app allows you to post a product brief with your specific requirements and receive inbound responses from pre-screened manufacturers who have been reviewed for cosmetic manufacturing credentials. This removes the cold-outreach phase entirely and gives you a vetted shortlist rather than a Google results page. Download AJ Cosmo Labs from the App Store to post your brief and start receiving qualified manufacturer responses.

Selling a kojic acid and tranexamic acid body serum in the EU is possible, but requires careful attention to the regulatory status of kojic acid specifically, which is actively restricted under the EU Cosmetics Regulation (EC) No. 1223/2009. Kojic acid's EU status: The Scientific Committee on Consumer Safety (SCCS) has evaluated kojic acid multiple times. As of the most recent published opinion, kojic acid is restricted to a maximum concentration of 1% in face care products intended to remain on the skin. The regulatory status for body products — including body serums — has been under review, and the SCCS has noted systemic exposure concerns for large-surface-area body applications at higher concentrations. Before launching in the EU, you must verify the current Annex III restriction entry for kojic acid and confirm that your formula's concentration and application area comply. EU regulations change, and what was permitted in a prior product design may not be compliant at the time of your launch. Transexamic acid in the EU: Tranexamic acid used at cosmetic concentrations (2–5%) is not currently restricted under EU cosmetics regulation and is considered a permitted cosmetic ingredient. It does not appear in Annexes II, III, IV, V, or VI of the EU Cosmetics Regulation at this writing, meaning it can be used subject to the general safety obligation. Responsible Person requirement: Every cosmetic product sold in the EU — including imports from the US — must have a designated Responsible Person (RP) established within the EU or EEA. The RP is legally accountable for regulatory compliance. If you're a US-based brand, you'll need to contract with an EU-based Responsible Person service, which typically costs €300 to €1,500 per year per product. Cosmetic Product Safety Report (CPSR): All EU cosmetics require a CPSR prepared and signed by a qualified safety assessor. For a brightening serum with restricted actives like kojic acid, expect to pay €500 to €2,000 for a CPSR, and factor in the assessor's review time (typically 4 to 8 weeks). Product Information File (PIF) and CPNP notification: You must maintain a PIF and notify your product through the EU's Cosmetic Products Notification Portal (CPNP) before placing it on the EU market. This is a technical administrative step but must be completed accurately. UK post-Brexit: The UK now operates under its own cosmetics regulation (UK Cosmetics Regulation, retained from EU law). The same Responsible Person structure applies, but it must be UK-based, separate from your EU RP. The bottom line: it is entirely feasible to sell a compliant kojic acid and tranexamic acid body serum in the EU, but you need to formulate within the current concentration restrictions for kojic acid, engage an EU Responsible Person, obtain a CPSR, and register on CPNP before your first sale. Working with a manufacturer who already has EU-compliant brightening formulas — ideally with existing CPSRs — dramatically reduces your compliance timeline and cost.

Packaging selection for a kojic acid and tranexamic acid body serum is not a branding decision alone — it is a formulation stability decision that directly determines the shelf life and the color integrity of your product. Kojic acid oxidizes in the presence of air, light, and heavy metal ions, which causes the formula to yellow or brown over time. The wrong packaging can ruin a perfectly stable formula within weeks of sitting on a shelf or in transit. The most critical packaging feature is an airless pump system. Airless pumps work by drawing product upward through a rising piston rather than introducing air into the reservoir. This eliminates the repeated oxygen exposure that occurs with a standard dip-tube pump every time the consumer presses the actuator. For a kojic acid serum, an airless pump can extend color stability and active integrity by several months compared to a conventional pump bottle. Most contract manufacturers who work regularly with vitamin C or kojic acid formulas will recommend airless as the default for this category. Opacity and UV protection are the second critical factors. Kojic acid degrades faster under UV and ambient light. Frosted, opaque, or UV-protective packaging — whether a white HDPE airless bottle, an opaque PET, or a dark-tinted glass — significantly reduces photo-degradation. Clear glass or transparent PET is cosmetically attractive but a poor choice for this formula type unless paired with opaque secondary packaging like an outer carton or a UV-protective sleeve. Material compatibility matters as well. Some pigments and plasticizers in lower-grade PET or polypropylene can leach into water-based acidic serums, potentially catalyzing oxidation. Request a compatibility report from your manufacturer confirming that the primary packaging has been tested with the actual formula. This is standard in GMP manufacturing but not always offered proactively. For a body serum specifically — where the fill volume is typically 150 to 250 ml — the most practical formats are: (1) airless pump bottle (30–200 ml), (2) opaque squeeze tube with a flip cap or nozzle, or (3) a disc-top or lotion pump with an opaque body. Squeeze tubes have the advantage of no internal air exposure after each use, making them a viable alternative to airless pumps and often lower in unit cost. From a sourcing standpoint, stock airless bottles in 100–200ml sizes start at around $0.80 to $1.80 per unit at 500+ units from domestic distributors; custom-molded airless components start at $1.50 to $4.00 per unit depending on tooling amortization and order volume. Packaging lead times are often the longest element of the production timeline — budget 6 to 10 weeks for custom components and 2 to 4 weeks for stock options. Have your packaging confirmed and on order before your formula development is finalized so both timelines run in parallel. AJ Cosmo Labs connects indie founders with packaging designers and component suppliers alongside cosmetic manufacturers, so you can align your formula and packaging sourcing in the same workflow rather than managing two separate vendor searches.